Bloom Health Partners Invited to U.K. MedTech Trade Mission

Bloom Health Partners Invited to U.K. MedTech Trade Mission

British Columbia government selects Bloom, a leader in Workplace Health-Tech, to join event designed to open doors, facilitate partnerships, expand business

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom" or theĀ "Company"), a global platform for operational health, announced it has been asked by the British Columbia Ministry of Jobs, Economic Recovery & Innovation to join a government-supported virtual trade mission to the United Kingdom.

The trade mission will showcase an exclusive group of innovative B.C. HealthTech companies which are expanding business and development in the U.K., the world's fifth largest economy. This will be the second year in a row Bloom has been including among a prestigious list of peers from the healthcare industry.

"We're delighted to participate in this trade mission supported by Trade and Invest British Columbia," said Andrew Morton, CEO of Bloom. "Opportunities are increasing for our Workplace Health-Tech platform comprised of onsite health services, laboratories and software. We're anticipating a productive trade mission among business leaders in the UK."

"With health issues top of mind among the workforce, employers in all industries are telling us there's a need to offer onsite healthcare as part of their business operations. UK based companies are faced with many of the same challenges as our North American clients. Our platform bridges onsite healthcare with our Bloom Shield software that helps securely engage employees with their health journey. In the coming decade, employees have the opportunity to see health, wellness and safety in the workplace as a differentiator when they evaluate their employment options," said Morton.

The trade mission, scheduled for May 9th - 13th, 2022 , will be delivered in association with GTM Global and Vita Healthcare Solutions. B.C. Trade and Invest, helps provincial companies access the U.K. markets and facilitate new partnerships.

"We're proud to add Bloom this year to our select roster of emerging life sciences and medtech leaders in British Columbia," said Laetitia MacDougall, BC Trade and Investment Representative - Europe. "B.C.'s growing life sciences industry is at the forefront of developments in biotechnology and pharmaceuticals, medical devices and medical technology. Bloom is a great example of a British Columbia growth story that can deliver innovation in healthcare and health-tech on an international scale," said MacDougall.

About Bloom Health Partners Inc.
Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) is a global platform for healthcare security, diagnostic testing and occupational health-tech. Our mission is to ensure that "unstoppable is possible" for businesses and their employees through innovative, customized healthcare models. Bloom offers a system for businesses and organizations that helps engage employees and creates strategies to manage health and safety. Our stable, scalable system is an integrated health-tech platform that securely manages data while delivering comprehensive workplace health and safety outcomes.

For more information: investors@bloomhealthpartners.com

On behalf of the board of directors,

Bloom Health Partners Inc.

Andrew Morton, Chief Executive Officer

Forward-Looking Statements

This news release includes forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward-looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in the Company's forward-looking statements include the potential that milestones may not be satisfied, acquisitions may not achieve expected benefits, financing requirements, and the other risk factors described in the Company's filings with Canadian securities regulators on www.sedar.com. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/122592

News Provided by Newsfile via QuoteMedia

BLMH:CNX
The Conversation (0)
Bloom Health Partners Announces Leadership Transition

Bloom Health Partners Announces Leadership Transition

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom" or the "Company"), a leading provider of diagnostic and health technology services, announces a leadership transition.

Effective September 30, 2022, Andrew Morton has stepped down as CEO of the Company to pursue other opportunities. Rosemary Elliston, COO of the Company, has been appointed to the position of Interim CEO. Mr. Morton will continue to support the Company as a Director.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Bloom Health Partners Announces New Location in Hawaii

Bloom Health Partners Announces New Location in Hawaii

New Bloom lab will support operations in the Honolulu area and surrounding region

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom" or the "Company"), a leading provider of operational health and health technology, announces the opening of a new location in in the Honolulu area.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Bloom Health Partners CEO to Speak at Health Benefits Nation Conference in Orlando

Bloom Health Partners CEO to Speak at Health Benefits Nation Conference in Orlando

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom" or the "Company"), a leading provider of operational health and health technology, announces its CEO, Andrew Morton, will speak on a panel at Health Benefits Nation Conference in Orlando, Florida on September 15th, 2022.

Mr. Morton will join co-panelists Eric Hargan, former U.S. Federal Deputy Secretary of the Department of Health and Human Services (DHHS), and Jeff Hogan, President of Upside Health Advisors. The panel titled "Incorporating Occupational Health into Value Based Health Strategies" will focus on workplace health and using data models to improve outcomes in occupational health in such areas as preventive care and mental health.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Bloom Health Partners Reports Profitable Fiscal Q3 2022 with $8.4 Million in Revenue

Bloom Health Partners Reports Profitable Fiscal Q3 2022 with $8.4 Million in Revenue

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom" or the "Company"), a leading provider of operational health and health technology, announces unaudited Fiscal Q2 2022 revenues of CAD $8.4M for the three months ended June 30th, 2022, bringing year-to-date revenues to CAD $24.9M for the first three quarters of Fiscal 2022.

Highlights in Fiscal Q2 2022:

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Bloom Health Partners Announces New Location to Serve Chicago and Surrounding Area

Bloom Health Partners Announces New Location to Serve Chicago and Surrounding Area

New Bloom lab in the Chicago area will serve as a foothold in the midwestern United States

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D84) ("Bloom" or the "Company"), a leading provider of operational health and health technology, announces the opening of a new location in the Chicago area.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Cyclomedica

Cyclopharm Signs US Agreement with HCA Healthcare for TechnegasĀ®

Cyclopharm Limited (ASX: CYC) is pleased to announce the signing of a major contract with Hospital Corporation of America Healthcare (HCA), one of the largest single healthcare providers in the United States. This agreement marks a significant milestone for the company which will allow the deployment of TechnegasĀ® in up to 169 nuclear medicine departments across HCAā€™s extensive network.1

Keep reading...Show less

Medtronic appoints Thierry PiƩton as Chief Financial Officer

Medtronic plc (NYSE:Ā MDT), a global leader in healthcare technology,Ā today announced that Thierry PiĆ©ton has been appointed Chief Financial Officer for the company, effective March 3, 2025 . He will report to Medtronic Chairman and Chief Executive Officer Geoff Martha and will join the Medtronic Executive Committee. PiĆ©ton joins Medtronic from Renault Group, where he has served as Chief Financial Officer since March 2022 . Gary Corona who has been serving as interim CFO, will continue in this role until PiĆ©ton joins Medtronic, after which Corona will become Senior Vice President, Corporate Finance and will remain on the Medtronic Executive Committee.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Medtronic appoints Thierry PiƩton as Chief Financial Officer

Medtronic plc (NYSE:Ā MDT), a global leader in healthcare technology,Ā today announced that Thierry PiĆ©ton has been appointed Chief Financial Officer for the company, effective March 3, 2025 . He will report to Medtronic Chairman and Chief Executive Officer Geoff Martha and will join the Medtronic Executive Committee. PiĆ©ton joins Medtronic from Renault Group, where he has served as Chief Financial Officer since March 2022 . Gary Corona who has been serving as interim CFO, will continue in this role until PiĆ©ton joins Medtronic, after which Corona will become Senior Vice President, Corporate Finance and will remain on the Medtronic Executive Committee.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less
Female doctor with clipboard talking to smiling female patient at hospital.

Revolutionizing Women's Health: Antifungal Innovation Brings New Investment Opportunities

The intersection of women's health and antifungal innovation represents a pivotal moment in healthcare, offering both transformative medical advancements and compelling investment opportunities.

The groundbreaking developments in antifungal treatments specifically targeting women's health issues present a substantial market potential, resulting in rising investor interest in this rapidly evolving sector.

Despite comprising half the global population, women face unique health challenges that have historically received insufficient attention and investment. Among these health challenges, vaginal candidiasis stands out as a persistent and widespread issue affecting millions of women worldwide.

Keep reading...Show less
Stethoscope connected to a phone with medical data overlay.

Top 5 Small-cap Medical Device Stocks (Updated January 2025)

The growing prevalence of chronic diseases like cancer and diabetes is driving increasing innovation in medical device technology. In 2024 alone,30 new devices were approved by the US Food and Drug Administration (FDA).

Wearable medical devices and the use of artificial intelligence in medical technology are two key trends in this sector. Moving forward, BCC Research projects that the global medical device industry will increase from US$810.4 billion in 2024 to US$1.3 trillion by 2029, expanding at a CAGR of 9.8 percent.

Investors who want exposure to this wave of growth may want to consider NASDAQ small-cap medical device stocks. Below, the Investing News Network has compiled a list of the top NASDAQ medical device companies based on yearly gains.

Keep reading...Show less

Latest Press Releases

Related News

Ɨ